Left ventricular alterations and end‐stage renal disease

Heart Disease: A Textbook of Cardiovascular Medicine.

(1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-3-415_3 · Cited by 4,119 · see citing works

McDonald's blood flow in arteries; theoretical, experimental and clinical principles

(1992) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(92)90079-y · Cited by 2,394 · see citing works

Impact of Aortic Stiffness on Survival in End-Stage Renal Disease

Blacher, J., Guerin, A. P., Pannier, B., Marchais, S. J., Safar, M. E., & London, G. M. (1999) · Circulation · doi:10.1161/01.cir.99.18.2434 · Cited by 2,138 · see citing works

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy

Foley, R. N., Parfrey, P. S., Harnett, J. D., Kent, G. M., Martin, C. J., Murray, D. C., & Barré, P. E. (1995) · Kidney International · doi:10.1038/ki.1995.22 · Cited by 1,294 · see citing works

Cardiac interstitium in health and disease: The fibrillar collagen network

Weber, K. T. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90360-4 · Cited by 1,060 · see citing works

Impact of left ventricular hypertrophy on survival in end-stage renal disease

Silberberg, J. S., Barré, P. E., Prichard, S. S., & Sniderman, A. D. (1989) · Kidney International · doi:10.1038/ki.1989.192 · Cited by 780 · see citing works

Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors

Harnett, J. D., Foley, R. N., Kent, G. M., Barré, P. E., Murray, D. L., & Parfrey, P. S. (1995) · Kidney International · doi:10.1038/ki.1995.132 · Cited by 718 · see citing works

Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention

Levin, A., Singer, J., Thompson, C. R., Ross, H., & Lewis, M. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90357-1 · Cited by 709 · see citing works

Carotid Arterial Stiffness as a Predictor of Cardiovascular and All-Cause Mortality in End-Stage Renal Disease

Blacher, J., Pannier, B., Guérin, A. P., Marchais, S. J., Safar, M. E., & London, G. M. (1998) · Hypertension · doi:10.1161/01.hyp.32.3.570 · Cited by 597 · see citing works

Cardiomyopathy of Overload

Epstein, F. H., & Katz, A. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001113220206 · Cited by 561 · see citing works

Cardiac and arterial interactions in end-stage renal disease

London, G. M., Guérin, A. P., Marchais, S. J., Pannier, B., Safar, M. E., Day, M., & Métivier, F. (1996) · Kidney International · doi:10.1038/ki.1996.355 · Cited by 473 · see citing works

Cardiovascular effects of anemia

Varat, M. A., Adolph, R. J., & Fowler, N. O. (1972) · American Heart Journal · doi:10.1016/0002-8703(72)90445-0 · Cited by 431 · see citing works

Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries.

Brilla, C. G., Janicki, J. S., & Weber, K. T. (1991) · Circulation Research · doi:10.1161/01.res.69.1.107 · Cited by 413 · see citing works

Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy

Foley, R. N., Parfrey, P. S., Morgan, J. M., Barré, P. E., Campbell, P., Cartier, P., Coyle, D., Fine, A., Handa, P., Kingma, I., et al. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00289.x · Cited by 405 · see citing works

Pathophysiology of anaemia: focus on the heart and blood vessels

Métivier, F., Marchais, S. J., Guérin, A. P., Pannier, B., & London, G. M. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/oxfordjournals.ndt.a027970 · Cited by 373 · see citing works

Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade.

London, G. M., Pannier, B., Guérin, A. P., Marchais, S. J., Safar, M. E., & Cuche, J. L. (1994) · Circulation · doi:10.1161/01.cir.90.6.2786 · Cited by 334 · see citing works

Diffuse Intermyocardiocytic Fibrosis in Uraemic Patients

Mall, G., Hüther, W., Schneider, J., Lundin, P., & Ritz, E. (1990) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/5.1.39 · Cited by 281 · see citing works

A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia.

Amann, K., Ritz, E., Wiest, G., et al. (1994) · Journal of the American Society of Nephrology · doi:10.1681/asn.v4101814 · Cited by 255 · see citing works

Increased systolic pressure in chronic uremia. Role of arterial wave reflections.

London, G. M., Guérin, A. P., Pannier, B., Marchais, S. J., Benetos, A., & Safar, M. E. (1992) · Hypertension · doi:10.1161/01.hyp.20.1.10 · Cited by 249 · see citing works

Wave reflections and cardiac hypertrophy in chronic uremia. Influence of body size.

Marchais, S. J., Guérin, A. P., Pannier, B., Levy, B. I., Safar, M. E., & London, G. M. (1993) · Hypertension · doi:10.1161/01.hyp.22.6.876 · Cited by 218 · see citing works

Transmural myocardial perfusion

Hoffman, J. I. E. (1987) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(87)90016-8 · Cited by 214 · see citing works

Load regulation of the properties of adult feline cardiocytes: growth induction by cellular deformation.

Mann, D. L., Kent, R. L., & Cooper, G. (1989) · Circulation Research · doi:10.1161/01.res.64.6.1079 · Cited by 206 · see citing works

Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients.

Harnett, J. D., Kent, G. M., Barré, P. E., Taylor, R., & Parfrey, P. S. (1994) · Journal of the American Society of Nephrology · doi:10.1681/asn.v471486 · Cited by 203 · see citing works

Pressure- and Volume-Induced Left Ventricular Hypertrophies Are Associated With Distinct Myocyte Phenotypes and Differential Induction of Peptide Growth Factor mRNAs

Calderone, A., Takahashi, N., Izzo, N. J., Thaik, C. M., & Colucci, W. S. (1995) · Circulation · doi:10.1161/01.cir.92.9.2385 · Cited by 193 · see citing works

Cardiac Disease in Chronic Uremia: Pathogenesis

London, G. M., & Parfrey, P. S. (1997) · Advances in Renal Replacement Therapy · doi:10.1016/s1073-4449(97)70029-3 · Cited by 188 · see citing works

Biological Determinants of Aldosterone-Induced Cardiac Fibrosis in Rats

Robert, V., Silvestre, J., Charlemagne, D., et al. (1995) · Hypertension · doi:10.1161/01.hyp.26.6.971 · Cited by 175 · see citing works

Heart Failure as a Complication of Hemodialysis Arteriovenous Fistula

Ahearn, D. J., & MAHER, J. F. (1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-77-2-201 · Cited by 172 · see citing works

Cardiac hypertrophy and arterial alterations in end-stage renal disease: hemodynamic factors.

London, G. M., Sj, M., Guérin, A. P., et al. (1993) · PubMed · Cited by 166 · see citing works

Myocardial interstitial fibrosis in experimental uremia—Implications for cardiac compliance

Mall, G., Rambausek, M., Neumeister, A., et al. (1988) · Kidney International · doi:10.1038/ki.1988.71 · Cited by 154 · see citing works

Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin.

Silberberg, J. S., Racine, N., Barré, P. E., & Sniderman, A. D. (1990) · PubMed · Cited by 153 · see citing works

Cardiac hypertrophy in chronically anemic fetal sheep: Increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1

Martin, C., Yu, A. Y., Jiang, B., Davis, L. E., Kimberly, D. J., Hohimer, A. R., & Semenza, G. L. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70433-8 · Cited by 145 · see citing works

Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study.

Pascual, J., Jl, T., Jl, M. M., Liaño, F., Jiménez-Mena, M., & Ortuño, J. Á. (1991) · PubMed · Cited by 136 · see citing works

Determinants of Left Ventricular Hypertrophy and Systolic Dysfunction in Chronic Renal Failure

Greaves, S., Gamble, G. D., Collins, J. F., WHALLEY, G. A., & Sharpe, D. N. (1994) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80670-6 · Cited by 127 · see citing works

Cardiac Abnormalities in Children With Sickle Cell Anemia

Lester, L. A., Sodt, P. C., Hutcheon, N., & Arcilla, R. A. (1990) · CHEST Journal · doi:10.1378/chest.98.5.1169 · Cited by 121 · see citing works

Endothelium-derived relaxing factor is important in mediating the high output state in chronic severe anemia

Anand, I. S., Chandrashekhar, Y., Wander, G. S., & Chawla, L. S. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00007-q · Cited by 116 · see citing works

Pathophysiology of cardiovascular damage in the early renal population

London, G. M. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.suppl_2.3 · Cited by 110 · see citing works

Exercise with Anemia

Oski, F. A., MARSHALL, B. E., COHEN, P. J., et al. (1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-44 · Cited by 104 · see citing works

Reversal of Left Ventricular Hypertrophy Following Recombinant Human Erythropoietin Treatment of Anaemic Dialysed Uraemic Patients

Cannella, G., Canna, G. L., Sandrini, M., Gaggiotti, M., Nordio, G., Movilli, E., Mombelloni, S., Visioli, O., & Maiorca, R. (1991) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/6.1.31 · Cited by 104 · see citing works

The role of mechanical and humoral factors in growth regulation of vascular smooth muscle and cardiac myocytes

Dzau, V. J. (1993) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-199301000-00004 · Cited by 100 · see citing works

Endothelin and cardiovascular remodelling in end-stage renal disease.

Demuth, K., Blacher, J., Guérin, A. P., et al. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/oxfordjournals.ndt.a027833 · Cited by 92 · see citing works

Effect of hemodialysis on blood volume distribution and cardiac output.

Chaignon, M., Chen, W. T., Tarazi, R. C., et al. (1981) · Hypertension · doi:10.1161/01.hyp.3.3.327 · Cited by 68 · see citing works

Relationship between left ventricular hypertrophy and plasma renin activity in chronic hemodialysis patients.

Vlahakos, D., Hahalis, G. N., Vassilakos, P. J., et al. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v8111764 · Cited by 61 · see citing works

Effects of Iron Repletion and Correction of Anemia on Norepinephrine Turnover and Thyroid Metabolism in Iron Deficiency

Beard, J. L., Tobin, B. W., & Smith, S. M. (1990) · Experimental Biology and Medicine · doi:10.3181/00379727-193-43040 · Cited by 58 · see citing works

Asymmetric septal hypertrophy and sympathetic overactivity in normotensive hemodialyzed patients

Bernardi, D., Bernini, L., Cini, G., Ghione, S., & Bonechi, I. (1985) · American Heart Journal · doi:10.1016/0002-8703(85)90560-5 · Cited by 46 · see citing works

Cardiovascular function in hemodialysis patients.

London, G. M., Sj, M., Guérin, A. P., et al. (1991) · PubMed · Cited by 43 · see citing works

The extracellular matrix in human myocardium: Part I: Collagens I, III, IV, and VI.

Speiser, B., Riess, C. F., & Schaper, J. (1991) · PubMed · Cited by 42 · see citing works

Changes in the alpha adrenergic system and increase in blood pressure with recombinant human erythropoietin (rHuEpo) therapy for renal anemia.

Müller, R., Steffen, H., Brunner, R., Saric, J., Pollok, M., Baldamus, C. A., & Kaufmann, W. (1991) · PubMed · Cited by 29 · see citing works

Pressure-overload cardiomyopathy in end-stage renal disease

London, G. M., Guérin, A. P., & Marchais, S. J. (1999) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-199903000-00005 · Cited by 18 · see citing works

Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia

Kuhn, V., Diederich, L., Keller, T. C. S., Kramer, C. M., Lückstädt, W., Panknin, C., Suvorava, T., Isakson, B. E., Kelm, M., & Cortese-Krott, M. M. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6954 · Cited by 469 · see citing works

Patterns of left ventricular hypertrophy in chronic kidney disease: an echocardiographic evaluation.

Sambi, R. S., Gaur, A. K., Hotchandani, R., et al. (2012) · PubMed · Cited by 8 · see citing works

The relationship between R wave peak time and left ventricular mass index in patients with end-stage renal disease on hemodialysis

Kalçık, M., Yetim, M., Doğan, T., et al. (2019) · International Urology and Nephrology · doi:10.1007/s11255-019-02297-w · Cited by 6 · see citing works

Left Ventricular Hypertrophy in Mild and Moderate Reduction in Kidney Function Determined Using Cardiac Magnetic Resonance Imaging and Cystatin C: The Multi-Ethnic Study of Atherosclerosis (MESA)

Moran, A. E., Katz, R., Jenny, N. S., Astor, B. C., Bluemke, D. A., Lima, J. A. C., Siscovick, D. S., Bertoni, A. G., & Shlipak, M. G. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.06.012 · Cited by 69 · see citing works

Deterioration of Deceleration Capacity of Heart Rate is Associated with Left Ventricular Hypertrophy in End-Stage Renal Disease Population.

Lin, T., Yang, W., Hsieh, M., Wu, C., & Lin, L. (2018) · Europe PMC (PubMed Central) · doi:10.6515/acs.201805_34(3).20180202a · Cited by 2 · see citing works

Echocardiographic documentation of regression of left ventricular hypertrophy in patients treated for essential hypertension

Schlant, R. C., Felner, J. M., Blumenstein, B. A., et al. (1982) · European Heart Journal · doi:10.1093/eurheartj/3.suppl_a.171 · Cited by 41 · see citing works